ATLASGE HealthCare Technologies (GEHC) Q3 2026 earnings results
GE HealthCare Technologies (GEHC) reported EPS of $1.34 against an analyst estimate of $1.21: a beat of $0.13 (10.7%). The quarter ended Sep 30, 2026; the company reported on Wednesday, October 28, 2026, before the open.
Status: Confirmed · cross-checked Nov 2 · Source: EODHD (calendar and fundamentals, cross-checked)
Notify me when GE HealthCare Technologies reports
Track GEHC free Add GE HealthCare Technologies to a free ATLAS watchlist.
GEHC Q3 2026 results at a glance
| EPS reported | $1.34 |
|---|---|
| EPS estimate | $1.21 |
| Surprise | Beat · +$0.13 (+10.7%) |
| Quarter ended | Sep 30, 2026 |
| Reported | Oct 28, 2026, before the open |
| Status | Confirmed · cross-checked Nov 2 |
EPS is as supplied by EODHD, in US dollars per share; whether it is adjusted or GAAP follows that source. This is GE HealthCare Technologies’s Q3 2026, a calendar-year company.
GE HealthCare Technologies EPS surprise history: last 3 quarters
GE HealthCare Technologies beat the EPS estimate in 2 of its last 3 reports, with an average surprise of +7.9%.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 28, 2026 | $1.21 | $1.34 | +10.7% | Beat | – |
| Jul 28, 2026 | $2.80 | $2.84 | +1.4% | In line | +17.6% |
| May 4, 2026 | $0.78 | $0.87 | +11.5% | Beat | 0.0% |
*Move: change in the closing price from the last close before the report day to the close the day after it. It is filled in a few trading days after each report.
GEHC stock reaction to the report
GEHC moved +6.62% in the first session that reflects the report (close of Oct 27, 2026 $71.11 to close of Oct 28, 2026 $75.82). Since the report: +7.68% (latest close $76.57 on Oct 30, 2026, against $71.11 before the reaction).
Next GEHC earnings report
GE HealthCare Technologies has not announced its next earnings date yet. This page shows a date only once it is confirmed. See the GEHC earnings calendar.
ATLAS fair value and signal for GEHC
| Last price | $79.66 (+4.0%) |
|---|---|
| ATLAS fair value | $95.22 (range $76.91–$117.89) · price is 16% below it |
| Chance of a higher close in 1 month | 51% (normal range $75.29–$84.48) |
These are model outputs from the same valuation and calibrated model as the GE HealthCare Technologies stock page. They describe an ordinary period and are not a forecast of any particular outcome.
GE HealthCare Technologies Q3 2026 earnings: frequently asked questions
Did GE HealthCare Technologies beat earnings estimates for Q3 2026?
GE HealthCare Technologies reported EPS of $1.34 against an analyst estimate of $1.21: a beat of $0.13 (10.7%).
When did GE HealthCare Technologies report Q3 2026 results?
GE HealthCare Technologies reported on Wednesday, October 28, 2026, before the open, for the quarter ended Wednesday, September 30, 2026.
How often does GEHC beat EPS estimates?
In its last 3 reports with a recorded result, GE HealthCare Technologies beat the EPS estimate 2 times; the average surprise was +7.9%. Past results do not predict the next one.
How does ATLAS confirm a result?
A result is published only after it is cross-checked: the EODHD earnings calendar and the EODHD fundamentals feed must show the same EPS for the same fiscal period, or the same value must appear in two consecutive checks. Unconfirmed figures are never published. If the figures are revised later, this page updates.
Educational information, not investment advice. Disclaimer